{{vm.title}}
25{{vm.includesText}}
{{item}}
{{vm.selectText}}
{{ vm.welcomeLabel.trim() }},
{{ vm.userName }}
{{ vm.text }}
{{vm.newUser1}} {{vm.newUser2}} {{vm.newUser3}} {{vm.newUser4}}
{{ vm.unknownUser }}
{{ vm.title }}
{{ vm.title }}
{{ vm.title }}
- {{ vm.siteSelectorList.flyout.cell1.heading }} {{ site.countryLocale }} {{ vm.siteSelectorList.flyout.cell1.global.countryLocale }}
{{ vm.closeTabLabel }}
- {{ vm.flyout.cell2.title }} {{ vm.flyout.cell2.newTabAllow }} {{ vm.flyout.cell2.title }}
- {{ vm.flyout.cell3.title }} {{ vm.flyout.cell3.newTabAllow }} {{ vm.flyout.cell3.title }}
- {{ vm.flyout.cell1.viewAll.label }} {{ vm.flyout.cell1.viewAll.newTabAllow }} {{ vm.flyout.cell1.viewAll.label }}
Leading from the front - UK Life Sciences
Leading from the front - UK Life Sciences
The UK is a byword for ground-breaking research and innovation in Life Sciences. With the industry one of those most challenged by the prospect of Brexit, what can US investors do to manage the change to come and position themselves for future growth?
Our new series will help US-based organisations cut through the macroeconomic and geopolitical noise surrounding the UK. We’ll empower you to navigate the UK business environment and make the most of its unique growth opportunities.
Part 5 of our UK Foreign Direct Investment (FDI) series looks at the life sciences industry.
An undisputed global trailblazer, the UK is a byword for ground-breaking research and innovation. But, with the life sciences industry one of those most challenged by the prospect of Brexit, what can US investors do to manage the incoming change and position themselves for future growth?
Our report looks at some of the key challenges posed to overseas investors by Brexit – and provides practical recommendations to minimise friction.
We also look beyond Brexit at some of the factors which continue to make the UK a magnet for life sciences organisations – and at some of the steps being taken to keep the industry in good health.
Download our report : Leading from the front - UK Life Sciences
A unique relationship between the US and UK
KPMG in the UK has a permanent UK-operated presence in the United States. KPMG UK (Transatlantic) LLC. provides advice and services to US companies with a presence in the UK, or those looking to establish one.
Staffed entirely by UK firm principals and professionals working together with the US firm's client service teams and specialists back in the UK, we provide on-the-ground support so US companies can navigate the UK business environment and capitalise on its opportunities.
To find out more, please contact us.
© 2020 KPMG LLP, a UK limited liability partnership, and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative, a Swiss entity. All rights reserved.
KPMG International Cooperative (“KPMG International”) is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.
